-
Glucan
Laminarin (500 micrograms/ml) was added to DCs in order to block their beta-glucan receptors.
-
dendritic cell
These DC still have functional receptors and are exposed to the receptor antagonist laminarin in order to block them.
-
dendritic cell
These bone marrow derived murine dendritic cells (BM-DC) were generated with GM-CSF according to Lutz et al. (J Immunol Methods 1999, 223: 77-92) and were used for the investigation of chemokine dependent CCR7 signalling.
-
Molecular entity
We used a MHC II presentation pathway targeting vector originally published by Wang et al. 1999 for the delivery of antigens in both murine and human DC.
-
curdlan
Using curdlan as a specific agonist of dectin-1, we have shown that this C-type lectin couple to Syk kinase leads to activation of ERK, JNK and p38 MAPKs, as well as NF-kappaB.
-
Mus musculus
These mice were generated with the intention to elucidate in vivo DC developmental regions in steady state and inflammation in situ.
-
cell
By selecting for cytokine receptor expression relevant to DC development, we were able to identify highly cycling Lin–c-KitintFlt3+M-CSFR+ cells with a distinct gene-expression profile in mouse bone marrow that, on a clonal level in vitro and as a population both in vitro and in vivo, efficiently generated plasmacytoid and conventional DCs but no other lineages, which increased in number after in vivo injection of the cytokine Flt3 ligand.
-
vaccine
DC based vaccines expressing the tumor antigens PSA or Her2/neu were produced in a pre-clinical work.
-
Cell culture
Co-cultures of mDCs and pDCs in response to CpGs, LPS and bacterial particles were studied to identify a possible cooperation between myeloid and plasmacytoid DCs in response to different microbial stimuli, and to characterize the mechanisms of this cooperation.
-
gamma-delta t cell
These T lymphocytes are exposed to HIV-1 to examine if this can directly modulate their functions or interfere with their cross-talk. Preliminary results indicated that, although virus exposure of gamma-delta T cells does not significantly affect their properties, HIV-exposed DCs exhibit a reduced capacity to deliver activation and proliferative signals to gamma-delta T lymphocytes. Moreover, a dysregulated pattern of cytokines and chemokines produced by both cell populations is observed in the presence of the virus.
-
T cell
These T cells are specific for the 0T-1-OVA antigen.
They were used to study the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
T cell
These T cells are specific for the P14-GP33 antigen.
They were used to study the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
T cell receptor
These TcR-Tg clones are specific for the P14-GP33 antigen.
In the individual T cells, we studied the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
T cell receptor
The TcR-Tg clones are specific for the 0T-1-OVA antigen.
In the individual T cells, we studied the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
dendritic cell
These DC were used to elicit CTL responses in a mouse model.
-
Mus musculus
The animal(s) were immunized in vivo with in vitro matured DC and / or treated using a maturation signal.
-
Homo sapiens
A significant number of patients was enrolled in the DC-based immunotherapy trial. After vaccination, vaccine-induced depigmentation and vitiligo were observed.
-
extracellular vesicular exosome
Exosomes were used to treat a chohort of 77 gastrointestinal stromal tumor (GIST) cancer patients.
-
Supernatant
This supernatant contains the infective MAGE-3 encoding viruses and the natural tumour peptides and is needed for metastatic melanoma vaccine production.
-
vaccine
The autologous, apoptotic, leukemic cells (Apo-DC) vaccine was given to 2 cohorts of patients: without additional adjuvants and with GM-CSF as an adjuvant. These two cohorts were monitored for 52 weeks. The clinical and immune monitoring data is being currently analyzed.